Skip to main content
. 2022 Apr 22;14(9):1760. doi: 10.3390/nu14091760

Table 3.

Weighted mean 25(OH)D (nmol/L), prevalence of vitD insufficiency (<50 nmol/L), and vitD supplement use by immigration status.

S-25(OH)D, (nmol/L) <50 (nmol/L) vitD Supplement Use
Non-Immigrant
Mean (SE)
Immigrant
Mean (SE)
95% CI p-Value Non-Immigrant
%
Immigrant
%
p-Value Non-Immigrant
%
Immigrant
%
p-Value
Diabetes 65.30 (4.05) 47.56 (4.46) −31.35, −4.13 0.013 31.43 61.63 <0.001 5.28 6.31 0.642
Heart disease 66.63 (2.15) 57.87 (3.80) −17.42, −0.11 0.048 32.12 38.38 <0.001 c c
Cancer 70.71 (2.86) 67.96 (5.71) −16.49, 10.98 0.681 29.08 32.28 <0.001 5.02 8.14 0.083
Asthma 59.13 (2.37) 54.23 (3.36) −12.97, 3.18 0.222 30.68 53.59 <0.001 c c
Inflammatory lung diseases a 63.87 (1.80) 53.27 (5.80) −22.09, 0.88 0.069 30.76 3841 <0.001 c c
CDs b 62.18 (1.80) 56.29 (2.49) −11.23, −0.53 0.033 31.35 47.38 <0.001 4.91 4.97 0.379
Self-rated general health (poor/fair) 58.69 (1.94) 48.68 (2.98) 3.61, 16.43 0.004 31.13 61.2 <0.001 5.28 4.37 0.807
Self-rated mental health (poor/fair) 59.83 (2.43) 47.55 (3.75) 4.12, 20.45 0.005 32.52 64.39 <0.001 5.67 3.67 0.271

a Inflammatory lung diseases: bronchitis + chronic obstructive pulmonary disease + emphysema; (age > 29 years). b CDs (chronic diseases): at least one of the listed CDs (diabetes, heart disease, cancer, asthma, and inflammatory lung diseases). c Data are not sufficient for analysis. Reference value; p ≤ 0.05; SE, standard error; CI, confidence interval.